BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 37999374)

  • 21. Construction of Histidine-Enriched Shark IgNAR Variable Domain Antibody Libraries for the Isolation of pH-Sensitive vNAR Fragments.
    Könning D; Hinz S; Grzeschik J; Schröter C; Krah S; Zielonka S; Kolmar H
    Methods Mol Biol; 2018; 1827():109-127. PubMed ID: 30196494
    [TBL] [Abstract][Full Text] [Related]  

  • 22. IgNAR antibody: Structural features, diversity and applications.
    Khalid Z; Chen Y; Yu D; Abbas M; Huan M; Naz Z; Mengist HM; Cao MJ; Jin T
    Fish Shellfish Immunol; 2022 Feb; 121():467-477. PubMed ID: 35077867
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthetic libraries of shark vNAR domains with different cysteine numbers within the CDR3.
    Cabanillas-Bernal O; Dueñas S; Ayala-Avila M; Rucavado A; Escalante T; Licea-Navarro AF
    PLoS One; 2019; 14(6):e0213394. PubMed ID: 31206542
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Shark New Antigen Receptor (IgNAR): Structure, Characteristics and Potential Biomedical Applications.
    Juma SN; Gong X; Hu S; Lv Z; Shao J; Liu L; Chen G
    Cells; 2021 May; 10(5):. PubMed ID: 34066890
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Isolation and characterization of an IgNAR variable domain specific for the human mitochondrial translocase receptor Tom70.
    Nuttall SD; Krishnan UV; Doughty L; Pearson K; Ryan MT; Hoogenraad NJ; Hattarki M; Carmichael JA; Irving RA; Hudson PJ
    Eur J Biochem; 2003 Sep; 270(17):3543-54. PubMed ID: 12919318
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human TNF cytokine neutralization with a vNAR from Heterodontus francisci shark: a potential therapeutic use.
    Camacho-Villegas T; Mata-Gonzalez T; Paniagua-Solis J; Sanchez E; Licea A
    MAbs; 2013; 5(1):80-5. PubMed ID: 23221782
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Unleashing the power of shark variable single domains (VNARs): broadly neutralizing tools for combating SARS-CoV-2.
    Cabanillas-Bernal O; Valdovinos-Navarro BJ; Cervantes-Luevano KE; Sanchez-Campos N; Licea-Navarro AF
    Front Immunol; 2023; 14():1257042. PubMed ID: 37753081
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Selection and Characterization of Anti-idiotypic Shark Antibody Domains.
    Könning D; Zielonka S; Kaempffe A; Jäger S; Kolmar H; Schröter C
    Methods Mol Biol; 2020; 2070():191-209. PubMed ID: 31625097
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Monoclonal antibodies for the identification and purification of vNAR domains and IgNAR immunoglobulins from the horn shark Heterodontus francisci.
    Juarez K; Dubberke G; Lugo P; Koch-Nolte F; Buck F; Haag F; Licea A
    Hybridoma (Larchmt); 2011 Aug; 30(4):323-9. PubMed ID: 21851231
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A novel shark single-domain antibody targeting OGT as a tool for detection and intracellular localization.
    Xi X; Xiao G; An G; Liu L; Liu X; Hao P; Wang JY; Song D; Yu W; Gu Y
    Front Immunol; 2023; 14():1062656. PubMed ID: 36855630
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In Vitro Maturation of a Humanized Shark VNAR Domain to Improve Its Biophysical Properties.
    Steven J; Ubah OC; Buschhaus M; Kovaleva M; Ferguson L; Porter AJ; Barelle CJ
    Methods Mol Biol; 2020; 2070():115-142. PubMed ID: 31625093
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Construction of Semisynthetic Shark vNAR Yeast Surface Display Antibody Libraries.
    Kolmar H; Grzeschik J; Könning D; Krah S; Zielonka S
    Methods Mol Biol; 2023; 2702():227-243. PubMed ID: 37679622
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Humanization of the Shark V
    Zhang YF; Sun Y; Hong J; Ho M
    Curr Protoc; 2023 Jan; 3(1):e630. PubMed ID: 36594750
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cytoplasmic and periplasmic expression of recombinant shark VNAR antibody in Escherichia coli.
    Leow HC; Fischer K; Leow YC; Braet K; Cheng Q; McCarthy J
    Prep Biochem Biotechnol; 2019; 49(4):315-327. PubMed ID: 30767708
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Progress in shark single-domain antibody].
    Liu X; Chen Q
    Sheng Wu Gong Cheng Xue Bao; 2020 Jun; 36(6):1069-1082. PubMed ID: 32597058
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transcriptomic analysis of immunoglobulin novel antigen receptor (IgNAR) heavy chain constant domains of brownbanded bamboo shark (Chiloscyllium punctatum).
    De Silva DPN; Tan E; Mizuno N; Hosoya S; Reza MS; Watabe S; Kinoshita S; Asakawa S
    Fish Shellfish Immunol; 2019 Jan; 84():370-376. PubMed ID: 30291985
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification and characterization of shark VNARs targeting the
    Gao Y; Wang R; Liu L; Feng S; Xi X; Yu W; Gu Y; Wang Y
    Artif Cells Nanomed Biotechnol; 2023 Sep; 51(1):509-519. PubMed ID: 37695066
    [No Abstract]   [Full Text] [Related]  

  • 38. Structural insights and biomedical potential of IgNAR scaffolds from sharks.
    Zielonka S; Empting M; Grzeschik J; Könning D; Barelle CJ; Kolmar H
    MAbs; 2015; 7(1):15-25. PubMed ID: 25523873
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficient Construction and Effective Screening of Synthetic Domain Antibody Libraries.
    Solemani Zadeh A; Grässer A; Dinter H; Hermes M; Schindowski K
    Methods Protoc; 2019 Feb; 2(1):. PubMed ID: 31164599
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Shark variable new antigen receptor biologics - a novel technology platform for therapeutic drug development.
    Kovaleva M; Ferguson L; Steven J; Porter A; Barelle C
    Expert Opin Biol Ther; 2014 Oct; 14(10):1527-39. PubMed ID: 25090369
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.